We are live on
!
Find out more
AAP
Ardsley Advisory Partners Portfolio holdings
AUM
$960M
1-Year Est. Return
207.76%
This Fund
S&P 500
This Quarter
Est. Return
+8.01%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$768M
AUM Growth
+$356M
(+86%)
Cap. Flow
+$337M
Cap. Flow
% of AUM
43.85%
Top 10 Holdings %
Top 10 Hldgs %
44.45%
Holding
216
New
71
Increased
33
Reduced
24
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$20.3M |
| 2 |
CELG
Celgene Corp
CELG
|
+$18.2M |
| 3 |
ENDP
Endo International plc
ENDP
|
+$17.3M |
| 4 |
HCA Healthcare
HCA
|
+$17.1M |
| 5 |
AKRX
Akorn Inc
AKRX
|
+$15.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Community Health Systems
CYH
|
+$16.3M |
| 2 |
SUNE
SUNEDISON, INC COM
SUNE
|
+$10.2M |
| 3 |
ProShares UltraShort NASDAQ Biotechnology
BIS
|
+$7.98M |
| 4 |
JMEI
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
|
+$6.51M |
| 5 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$6.29M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.23% |
| 2 | Real Estate | 9.91% |
| 3 | Technology | 7.9% |
| 4 | Utilities | 5.91% |
| 5 | Energy | 5.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Xylem
XYL
$29.7B
| $2.92M | 0.38% |
80,000
-5,000
| -6% | -$181K |
|
52
Carnival Corporation Ltd
CCL
$38.7B
| $2.86M | 0.37% |
52,500
+35,500
| +209% | +$1.84M |
|
53
Itron
ITRI
$4.75B
| $2.8M | 0.37% |
77,500
+7,500
| +11% | +$265K |
|
|
AKRX
54
CALL
DELISTED
Akorn Inc
AKRX
| $2.8M | 0.36% |
75,000
+68,000
| +971% | +$2.13M |
|
|
55
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.23M
| $2.15M | 0.28% |
9,375
-31,031
| -77% | -$7.98M |
|
56
CALL
Devon Energy
DVN
$49.2B
| $1.92M | 0.25% |
+60,000
| New | +$2.46M |
|
57
CALL
Bank of America
BAC
$439B
| $1.68M | 0.22% |
100,000
+50,000
| +100% | +$846K |
|
|
VTNR
58
DELISTED
Vertex Energy, Inc
VTNR
| $1.65M | 0.21% |
978,067
+332,905
| +52% | +$666K |
|
59
Pfizer
PFE
$144B
| $1.61M | 0.21% |
52,700
| – | – |
|
|
REGI
60
DELISTED
Renewable Energy Group, Inc.
REGI
| $1.39M | 0.18% |
+150,000
| New | +$1.26M |
|
|
EVA
61
DELISTED
Enviva Inc.
EVA
| $1.13M | 0.15% |
+62,500
| New | +$951K |
|
|
ENOC
62
DELISTED
EnerNOC, Inc.
ENOC
| $1.12M | 0.15% |
290,000
+190,000
| +190% | +$1.11M |
|
63
CALL
Citigroup
C
$222B
| $1.03M | 0.13% |
20,000
-30,000
| -60% | -$1.59M |
|
|
MXWL
64
DELISTED
Maxwell Technologies Inc
MXWL
| $1.03M | 0.13% |
144,500
-510,000
| -78% | -$3.31M |
|
|
SPWR
65
DELISTED
SunPower Corporation Common Stock
SPWR
| $900K | 0.12% |
+45,810
| New | +$766K |
|
66
STAAR Surgical
STAA
$1.13B
| $668K | 0.09% |
93,612
-510,000
| -84% | -$4.13M |
|
|
FL
67
PUT
DELISTED
Foot Locker
FL
| $651K | 0.08% |
+10,000
| New | +$665K |
|
|
AGN
68
DELISTED
Allergan plc
AGN
| $625K | 0.08% |
2,000
-1,000
| -33% | -$298K |
|
69
Aecom
ACM
$9.57B
| $601K | 0.08% |
+20,000
| New | +$601K |
|
70
CALL
FMC
FMC
$1.37B
| $587K | 0.08% |
+17,295
| New | +$592K |
|
|
71
FMC
FMC
$1.37B
| $587K | 0.08% |
+17,295
| New | +$592K |
|
|
CST
72
DELISTED
CST Brands, Inc.
CST
| $587K | 0.08% |
15,000
-5,000
| -25% | -$183K |
|
|
PLXP
73
DELISTED
PLx Pharma Inc. Common Stock
PLXP
| $560K | 0.07% |
6,250
+625
| +11% | +$60K |
|
74
PUT
Texas Instruments
TXN
$253B
| $548K | 0.07% |
+10,000
| New | +$558K |
|
|
PRXL
75
DELISTED
Parexel International Corp
PRXL
| $511K | 0.07% |
+7,500
| New | +$488K |
|
Similar funds
NA
MK
QIM
JVBC
TFP
UWPG
LOAMU
PHS
Ardsley Advisory Partners's Q4 2015 Portfolio in Review
As of Q4 2015, Ardsley Advisory Partners held 216 positions worth $768M, up 86% from $412M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Ardsley Advisory Partners deployed $337M of net new capital in Q4 2015, opening 71 new positions and adding to 33 existing holdings. Its largest new stake was Bausch Health: 180,500 shares worth $18.3M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Real Estate and Technology.
On the sell side, the largest reduction was ProShares UltraShort NASDAQ Biotechnology, an estimated $7.98M trimmed.
- Ardsley Advisory Partners's largest Q4 2015 buy was Bausch Health: 180,500 shares worth $18.3M.
- Ardsley Advisory Partners added most to Akorn Inc in Q4 2015, an estimated $15.4M increase.
- Ardsley Advisory Partners's biggest Q4 2015 reduction was ProShares UltraShort NASDAQ Biotechnology, cutting an estimated $7.98M.
- Ardsley Advisory Partners fully exited Community Health Systems in Q4 2015, selling an estimated $16.3M.
- Ardsley Advisory Partners's ten largest holdings make up 44% of its $768M portfolio in Q4 2015.
- Ardsley Advisory Partners opened 71 new positions and closed 76 in Q4 2015.
- Ardsley Advisory Partners's portfolio value rose 86% quarter-over-quarter to $768M.
Based on Ardsley Advisory Partners's 13F filing for Q4 2015, filed 16 Feb 2016.